Form 8-K - Current report:
SEC Accession No. 0001213900-25-063799
Filing Date
2025-07-14
Accepted
2025-07-14 17:24:57
Documents
14
Period of Report
2025-07-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0248909-8k_180life.htm   iXBRL 8-K 51020
2 FIRST AMENDMENT TO EXECUTIVE CONSULTING AGREEMENT ENTERED INTO ON JULY 12, 2025 ea024890901ex10-5_180life.htm EX-10.5 13251
  Complete submission text file 0001213900-25-063799.txt   283082

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE atnf-20250711.xsd EX-101.SCH 3786
4 XBRL DEFINITION FILE atnf-20250711_def.xml EX-101.DEF 26628
5 XBRL LABEL FILE atnf-20250711_lab.xml EX-101.LAB 36679
6 XBRL PRESENTATION FILE atnf-20250711_pre.xml EX-101.PRE 25252
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0248909-8k_180life_htm.xml XML 5814
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 251122481
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)